ClinConnect ClinConnect Logo
Search / Trial NCT06601270

SCAD : a Registry of Spontaneous Coronary Artery Dissection

Launched by EUROPEAN SOCIETY OF CARDIOLOGY · Sep 13, 2024

Trial Information

Current as of August 26, 2025

Recruiting

Keywords

ClinConnect Summary

The SCAD study is looking at a condition called Spontaneous Coronary Artery Dissection (SCAD), which is a serious heart problem that can happen without the typical risks associated with heart disease. This condition primarily affects younger women and can lead to sudden heart issues. The goal of this trial is to create the first large registry in Europe to gather information about SCAD, helping doctors better understand how to diagnose and treat it. By collecting data from many patients, researchers hope to improve guidelines for treatment and increase awareness among healthcare providers.

To participate in the study, you need to be at least 18 years old and have been diagnosed with SCAD within the last 10 years. You’ll also need to provide consent to join the study. If you decide to participate, your experiences and medical information will contribute to important research that aims to improve care for others with this condition. This is a great opportunity to help advance the understanding of SCAD and potentially benefit future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient having signed an Informed Consent
  • Patient aged 18 years and over
  • SCAD clinical diagnosis within the past 10 years and available coronary angiographic imagery
  • Exclusion Criteria:
  • Patient unwilling or unable to consent
  • Patients with iatrogenic or atherosclerotic coronary dissection

About European Society Of Cardiology

The European Society of Cardiology (ESC) is a leading non-profit organization dedicated to advancing cardiovascular medicine through research, education, and advocacy. With a commitment to improving patient outcomes, the ESC sponsors and conducts clinical trials that explore innovative treatments and interventions in cardiology. By fostering collaboration among healthcare professionals, researchers, and industry partners, the ESC aims to translate scientific discoveries into clinical practice, enhance the understanding of cardiovascular diseases, and ultimately improve the quality of care for patients across Europe and beyond.

Locations

London, , United Kingdom

Vienna, , Austria

Nijmegen, , Netherlands

Odense, , Denmark

Copenhagen, , Denmark

Breda, , Netherlands

Aarhus, , Denmark

Gent, , Belgium

Madrid, , Spain

Bristol, , United Kingdom

Stuttgart, , Germany

Tehran, , Iran, Islamic Republic Of

Sint Niklaas, , Belgium

Leuven, , Belgium

Bodelwyddan, , United Kingdom

Sarajevo, , Bosnia And Herzegovina

Amadora, , Portugal

Braga, , Portugal

Roeselare, , Belgium

Prague, , Czech Republic

Liège, , Belgium

Edegem, , Belgium

Sao Paulo, , Brazil

Banska Bystrica, , Slovakia

Bournemouth, , United Kingdom

Massy, , France

Ashford, , United Kingdom

Nicosia, , Cyprus

Milan, , Italy

Besançon, , France

Wiener Neustadt, , Austria

Vienna, , Austria

Brussels, , Belgium

Monza, , Italy

Singapore, , Singapore

Buenos Aires, , Argentina

Innsbruck, , Austria

Vienna, , Austria

Bruges, , Belgium

Brussels, , Belgium

Genk, , Belgium

Gent, , Belgium

Ottignies, , Belgium

Sao Paulo, , Brazil

São Paulo, , Brazil

Split, , Croatia

Pardubice, , Czech Republic

Hellerup, , Denmark

Clermont Ferrand, , France

Le Coudray, , France

Lyon, , France

Pessac, , France

Bad Rothenfelde, , Germany

Berlin, , Germany

Hamburg, , Germany

Athens, , Greece

Kozani, , Greece

Bergamo, , Italy

Foggia, , Italy

Genoa, , Italy

Mantua, , Italy

Milan, , Italy

Milan, , Italy

Alkmaar, , Netherlands

Auckland, , New Zealand

Bergen, , Norway

Warsaw, , Poland

Tondela, , Portugal

évora, , Portugal

Belgrade, , Serbia

Nis, , Serbia

Leicester, , United Kingdom

London, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Adham GHARIEB, PharmD

Study Director

ESC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported